Answers are grounded in this paper and cite their sources.
Here, we report 19 consecutive patients who were diagnosed with adult T-cell leukemia and lymphoma (ATLL) and treated at Hyogo Prefectural Amagasaki Hospital between January 2008 and June 2011. Seven had the acute, 8 had the lymphoma, and 4 had the chronic type of the disease. The age range was 53 to 95, with a median of 67. The male to female ratio was 17 to 2. Sixteen of 17 were born in Southwest Japan and had moved to the Hanshin industrial area during their young adulthood. Acute-type patients showed the most aggressive clinical behavior, including a poor performance status, hepatosplenomegaly, pleural fluid/ascites, and high levels of lactate dehydrogenase, soluble interleukin-2 receptor, and serum calcium. Diagnosis of the acute type was readily established in the laboratory on the basis of the characteristic morphology of the circulating neoplastic lymphocytes and activated mature T-cell immunophenotype by flow cytometry, while the histopathological features of lymph nodes overlapped with those of other types of peripheral T-cell lymphoma or Hodgkin lymphoma. Cytogenetic studies revealed a complex karyotype in 8 cases and add(14)(q32) in 2. Five acute and 5 lymphoma-type patients were initially treated with the LSG15 or mLSG15 chemotherapy regimen. Six patients achieved a partial or better response, and 4 lymphoma-type patients showed >1 year survival. The marked male predominance most likely reflects the unique demographic configuration of the Amagasaki area. As the aging of patients with ATLL seems to be a nationwide trend within Japan, the development of a treatment strategy that can be tolerated by elderly patients is required.
No takes yet. Share an insight, caveat, or question.
Ohno et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: